Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Good News For Walmart Isn’t So Great For Everybody Else
Good News For Walmart Isn’t So Great For Everybody Else

Walmart (NYSE: WMT) had a better-than-expected quarter and raised its full-year guidance, but the news isn’t as great as it may seem. The gains were driven by isolated segments that confirm

Berry Global, The Backbone Of Consumer Packaging You Should Own
Berry Global, The Backbone Of Consumer Packaging You Should Own

Berry Global Group (NYSE: BERY) is one of those businesses that do not seem to let off the gas pedal, significantly when all other sectors lag in performance. As a result, Berry has been

Copart Auctions, A Little Outlet For America's Car Problems
Copart Auctions, A Little Outlet For America's Car Problems

Shares of Copart (NASDAQ: CPRT) reached an all-time high price of $82.81 in the after-market hours of Wednesday evening, amid monstrous momentum buildup throughout 2022, seemingly continuing into

Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings
Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX), maker of Cystic fibrosis drugs, rallied to a record high on May 2 after a better-than-expected first-quarter earnings report. 

Net income of $3.05 a

Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings
Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX), maker of Cystic fibrosis drugs, rallied to a record high on May 2 after a better-than-expected first-quarter earnings report. 

Net income of $3.05 a

Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings
Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX), maker of Cystic fibrosis drugs, rallied to a record high on May 2 after a better-than-expected first-quarter earnings report. 

Net income of $3.05 a

Copart Auctions, A Little Outlet For America's Car Problems
Copart Auctions, A Little Outlet For America's Car Problems

Shares of Copart (NASDAQ: CPRT) reached an all-time high price of $82.81 in the after-market hours of Wednesday evening, amid monstrous momentum buildup throughout 2022, seemingly continuing into

Copart Auctions, A Little Outlet For America's Car Problems
Copart Auctions, A Little Outlet For America's Car Problems

Shares of Copart (NASDAQ: CPRT) reached an all-time high price of $82.81 in the after-market hours of Wednesday evening, amid monstrous momentum buildup throughout 2022, seemingly continuing into

ServiceNow Serves Up A Reversal, Now!
ServiceNow Serves Up A Reversal, Now!

ServiceNow (NASDAQ: NOW) surprised the market when it announced a massive share repurchase authorization. The authorization was announced at the shareholder event and is worth $1.5 billion. That’s

Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

On May 15th, mid-cap biotechnology company Sarepta Therapeutics was the big winner in an otherwise quiet day for the Russell 1000 Index. Sarepta jumped more than 30% after an FDA advisory panel

The TJX Companies Inc: A Good Pick for 2023?
The TJX Companies Inc: A Good Pick for 2023?

The shifting consumer environment has affected the TJX Companies Inc. (NYSE: TJX). Consumers have shifted from discretionary items to staples, trading down from higher-tier retailers to low-price

Is Unity the Best Performing Game Developer in Q2?
Is Unity the Best Performing Game Developer in Q2?

Shares of video game developer Unity Software Inc. (NYSE: U) are trading for the same price this time last year. After reaching all-time highs in November of 2021, the San Francisco headquartered

How to Invest in Telehealth and Telemedicine Stocks
How to Invest in Telehealth and Telemedicine Stocks

Coming into prominence during the COVID-19 pandemic, telemedicine stocks saw increases in price and profitability in the past five years. As relaxed government regulations allowed service

How to Invest in Telehealth and Telemedicine Stocks
How to Invest in Telehealth and Telemedicine Stocks

Coming into prominence during the COVID-19 pandemic, telemedicine stocks saw increases in price and profitability in the past five years. As relaxed government regulations allowed service

Target’s Guidance Looms Over The Market
Target’s Guidance Looms Over The Market

Target (NYSE: TGT) reported a better-than-expected quarter driven by the underlying momentum within the US economy. That’s the good news. The bad news is that outlook is weak, echoing home

Want Clean Energy? Siemens May Be Pointing To A Breakout
Want Clean Energy? Siemens May Be Pointing To A Breakout

Shares of Siemens Aktiengesellschaft (OTCMKTS: SIEGY) showcased a massive 78% rally after 2022, full of natural growth, paired with enriched multiples on these expanding financials. Today, Siemens

Want Clean Energy? Siemens May Be Pointing To A Breakout
Want Clean Energy? Siemens May Be Pointing To A Breakout

Shares of Siemens Aktiengesellschaft (OTCMKTS: SIEGY) showcased a massive 78% rally after 2022, full of natural growth, paired with enriched multiples on these expanding financials. Today, Siemens

Up Over 2,600% in 5 Years, Wall Street Still Calls Celsius a Buy
Up Over 2,600% in 5 Years, Wall Street Still Calls Celsius a Buy

Whether measured in Celsius or Fahrenheit, Celsius Holdings, Inc. (NASDAQ: CELH) is red hot!

Shares of the healthy energy drink maker soared to an all-time high last week following another

STMicroelectronics, NetEase, HP Enterprise: Undervalued Techs?
STMicroelectronics, NetEase, HP Enterprise: Undervalued Techs?

Whether you believe markets are always efficient, or whether you believe some stocks are mispriced, you undoubtedly want to buy low and sell high.  

Some stocks are considered mispriced if they

Moon Surgical Appoints Fred Moll, MD, as Board Chair and Raises Additional $55.4 Million in New Funding with Leading Investors Sofinnova Partners and NVIDIA
Moon Surgical Appoints Fred Moll, MD, as Board Chair and Raises Additional $55.4 Million in New Funding with Leading Investors Sofinnova Partners and NVIDIA

Fresh financing to accelerate the commercialization of Maestro System

 

PARIS, FRANCE and SAN FRANCISCO, CA / ACCESSWIRE / May 17, 2023 / Moon Surgical, a French-American pioneer in

Moon Surgical ernennt Dr. Fred Moll zum Chair des Board of Directors und nimmt weitere 55,4 Millionen Dollar in einer neuen Finanzierung mit den führenden Investoren Sofinnova Partners und NVIDIA ein
Moon Surgical ernennt Dr. Fred Moll zum Chair des Board of Directors und nimmt weitere 55,4 Millionen Dollar in einer neuen Finanzierung mit den führenden Investoren Sofinnova Partners und NVIDIA ein

Neue Finanzierung soll die Vermarktung des Maestro-Systems beschleunigen

 

PARIS, FRANKREICH und SAN FRANCISCO, KALIFORNIEN, USA / ACCESSWIRE / 17. Mai 2023 / Moon Surgical, ein

Moon Surgical ernennt Dr. Fred Moll zum Chair des Board of Directors und nimmt weitere 55,4 Millionen Dollar in einer neuen Finanzierung mit den führenden Investoren Sofinnova Partners und NVIDIA ein
Moon Surgical ernennt Dr. Fred Moll zum Chair des Board of Directors und nimmt weitere 55,4 Millionen Dollar in einer neuen Finanzierung mit den führenden Investoren Sofinnova Partners und NVIDIA ein

Neue Finanzierung soll die Vermarktung des Maestro-Systems beschleunigen

 

PARIS, FRANKREICH und SAN FRANCISCO, KALIFORNIEN, USA / ACCESSWIRE / 17. Mai 2023 / Moon Surgical, ein

Moon Surgical ernennt Dr. Fred Moll zum Chair des Board of Directors und nimmt weitere 55,4 Millionen Dollar in einer neuen Finanzierung mit den führenden Investoren Sofinnova Partners und NVIDIA ein
Moon Surgical ernennt Dr. Fred Moll zum Chair des Board of Directors und nimmt weitere 55,4 Millionen Dollar in einer neuen Finanzierung mit den führenden Investoren Sofinnova Partners und NVIDIA ein

Neue Finanzierung soll die Vermarktung des Maestro-Systems beschleunigen

 

PARIS, FRANKREICH und SAN FRANCISCO, KALIFORNIEN, USA / ACCESSWIRE / 17. Mai 2023 / Moon Surgical, ein

Moon Surgical Appoints Fred Moll, MD, as Board Chair and Raises Additional $55.4 Million in New Funding with Leading Investors Sofinnova Partners and NVIDIA
Moon Surgical Appoints Fred Moll, MD, as Board Chair and Raises Additional $55.4 Million in New Funding with Leading Investors Sofinnova Partners and NVIDIA

Fresh financing to accelerate the commercialization of Maestro System

 

PARIS, FRANCE and SAN FRANCISCO, CA / ACCESSWIRE / May 17, 2023 / Moon Surgical, a French-American pioneer in